Why Investors Are Looking at Black Blood — and What Health Equity Really Means in 2025
Health equity is no longer just a moral argument — it is a measurable, fundable, scalable opportunity. Black Blood sits at the centre of one of the UK’s most urgent and overlooked health challenges. Here’s why that matters to investors.
The conversation around health equity investment has changed. It used to be framed almost entirely in moral terms — the right thing to do, the ethical imperative, the social responsibility angle. Those things are still true. But they are no longer the whole conversation.
What serious impact investors are now asking is different: Where is the need most acute? Where is the solution most clearly defined? Where is the community trust already built? And where can capital create outcomes that are genuinely measurable?
Black Blood answers all four questions.
The need is acute and quantified
NHS Blood and Transplant requires 250 blood donations daily to treat sickle cell patients. They have called for 16,000 new Black heritage donors. Currently, they can meet approximately half of demand for the Ro blood subtype that Black patients most need. This is not a problem that money alone can solve — but it is a problem that community infrastructure can dramatically improve, and that infrastructure requires investment.
The solution is clear
Black Blood is not asking the NHS to change its entire system. We are building the community layer that the system lacks — ambassador programmes, culturally fluent engagement, donor recognition, and the trusted relationships that turn a hesitant potential donor into a committed regular one. This is proven methodology. It works. It just hasn’t been properly resourced in this community.
The trust is already there
The single biggest barrier to Black blood donation is not lack of awareness. It is lack of trust — in the system, in campaigns that don’t speak to us, in the feeling of not being expected. Black Blood was built from within the community. That trust cannot be purchased. It can be resourced.
The outcomes are measurable
Donor registrations. First donations. Repeat donations. Ro blood units available. Sickle cell patients receiving better-matched transfusions. These are trackable. They compound. A donor who gives every 16 weeks for ten years is not one unit of impact — they are thirty.
If you represent a foundation, impact fund, NHS body, or corporate partner who wants to put capital behind an outcome that is urgent, measurable, and community-led — we want to hear from you.
Inspired? Register as a donor or share your story.